Prevalence of Apparent Treatment-Resistant Hypertension.
作者信息
Jones Daniel W, Clark Donald, Wofford Marion R
机构信息
From the Department of Medicine, University of Mississippi Medical Center, Jackson.
出版信息
Hypertension. 2019 Feb;73(2):286-287. doi: 10.1161/HYPERTENSIONAHA.118.12271.
Abstract
摘要
相似文献
1
Prevalence of Apparent Treatment-Resistant Hypertension.显性治疗抵抗性高血压的患病率
Hypertension. 2019 Feb;73(2):286-287. doi: 10.1161/HYPERTENSIONAHA.118.12271.
2
Prevalence of apparent treatment-resistant hypertension among individuals with CKD.CKD 患者中明显治疗抵抗性高血压的患病率。
Clin J Am Soc Nephrol. 2013 Sep;8(9):1583-90. doi: 10.2215/CJN.00550113. Epub 2013 Jul 18.
3
Prevalence of Apparent Treatment-Resistant Hypertension in Chronic Kidney Disease in Two Large US Health Care Systems.在美国两大医疗保健系统中慢性肾脏病中明显治疗抵抗性高血压的流行情况。
Clin J Am Soc Nephrol. 2022 Oct;17(10):1457-1466. doi: 10.2215/CJN.04110422. Epub 2022 Sep 9.
4
Prevalence of Apparent Treatment-Resistant Hypertension in the United States.美国显性治疗抵抗性高血压的流行情况。
Hypertension. 2019 Feb;73(2):424-431. doi: 10.1161/HYPERTENSIONAHA.118.12191.
5
Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack.有中风或短暂性脑缺血发作病史的个体中明显的难治性高血压
Am J Med. 2015 Jul;128(7):707-14.e2. doi: 10.1016/j.amjmed.2015.02.008. Epub 2015 Mar 10.
6
Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease.冠心病患者中治疗抵抗性高血压的患病率、预测因素和结局。
Am J Med. 2014 Jan;127(1):71-81.e1. doi: 10.1016/j.amjmed.2013.07.038. Epub 2013 Nov 7.
7
What is the prevalence of resistant hypertension in the United States?美国耐药性高血压的患病率是多少？
Curr Opin Cardiol. 2012 Jul;27(4):386-91. doi: 10.1097/HCO.0b013e328353ad6e.
8
Self-reported hypertension and use of antihypertensive medication among adults - United States, 2005-2009.成年人自我报告的高血压患病率和使用降压药物情况-美国，2005-2009 年。
MMWR Morb Mortal Wkly Rep. 2013 Apr 5;62(13):237-44.
9
Prevalence of Apparent Treatment-Resistant Hypertension in the United States According to the 2017 High Blood Pressure Guideline.根据 2017 年高血压指南，美国明显治疗抵抗性高血压的流行情况。
Mayo Clin Proc. 2019 May;94(5):776-782. doi: 10.1016/j.mayocp.2018.12.033.
10
State of hypertension management in the United States: confluence of risk factors and the prevalence of resistant hypertension.美国高血压管理现状：危险因素的汇聚与顽固性高血压的患病率
J Clin Hypertens (Greenwich). 2008 Feb;10(2):130-9. doi: 10.1111/j.1751-7176.2008.07309.x.
引用本文的文献
1
Resistant Hypertension Management: Comparison of the 2017 American and 2018 European High Blood Pressure Guidelines.难治性高血压管理：2017 年美国和 2018 年欧洲高血压指南比较。
Curr Hypertens Rep. 2019 Jul 18;21(9):67. doi: 10.1007/s11906-019-0974-3.
本文引用的文献
1
Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.耐药性高血压：检测、评估与管理：美国心脏协会科学声明。
Hypertension. 2018 Nov;72(5):e53-e90. doi: 10.1161/HYP.0000000000000084.
2
Measure Accurately, Act Rapidly, and Partner With Patients (MAP) improves hypertension control in medically underserved patients: Care Coordination Institute and American Medical Association Hypertension Control Project Pilot Study results.精准测量、快速行动、与患者合作（MAP）改善医疗资源不足患者的高血压控制：医疗协调协会和美国医学协会高血压控制项目试点研究结果。
J Clin Hypertens (Greenwich). 2018 Jan;20(1):79-87. doi: 10.1111/jch.13141. Epub 2018 Jan 5.
3
Systolic Blood Pressure Intervention Trial (SPRINT) and Target Systolic Blood Pressure in Future Hypertension Guidelines.收缩压干预试验（SPRINT）与未来高血压指南中的目标收缩压
Hypertension. 2016 Aug;68(2):318-23. doi: 10.1161/HYPERTENSIONAHA.116.07575. Epub 2016 Jun 27.
4
Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment Failure.难治性高血压：抗高血压治疗失败的一种新表型。
Hypertension. 2016 Jun;67(6):1085-92. doi: 10.1161/HYPERTENSIONAHA.116.06587. Epub 2016 Apr 18.
5
Resistant hypertension and aldosterone: an update.耐药性高血压与醛固酮：最新进展。
Can J Cardiol. 2012 May;28(3):318-25. doi: 10.1016/j.cjca.2012.03.010. Epub 2012 Apr 21.
6
Efficacy of spironolactone therapy in patients with true resistant hypertension.螺内酯治疗真性难治性高血压患者的疗效。
Hypertension. 2010 Jan;55(1):147-52. doi: 10.1161/HYPERTENSIONAHA.109.140988. Epub 2009 Oct 26.
7
Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.难治性高血压：诊断、评估与治疗。美国心脏协会高血压研究理事会专业教育委员会的科学声明。
Hypertension. 2008 Jun;51(6):1403-19. doi: 10.1161/HYPERTENSIONAHA.108.189141. Epub 2008 Apr 7.
8
Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure.氢氯噻嗪和氯噻酮对动态血压和诊室血压的降压效果比较
Hypertension. 2006 Mar;47(3):352-8. doi: 10.1161/01.HYP.0000203309.07140.d3. Epub 2006 Jan 23.
Zotero 插件